After menopause, when estrogen levels decrease, there is room for the activity of anthropogenic substances with estrogenic properties - endocrine disruptors (EDs) - that can interfere with bone remodeling and changes in calcium-phosphate metabolism. Selected unconjugated EDs of the bisphenol group - BPA, BPS, BPF, BPAF, and the paraben family - methyl-, ethyl-, propyl-, butyl-, and benzyl-parabens - were measured by high performance liquid chromatography-tandem mass spectrometry in the plasma of 24 postmenopausal women. Parameters of calcium-phosphate metabolism and bone mineral density were assessed. Osteoporosis was classified in 14 women, and 10 women were put into the control group. The impact of EDs on calcium-phosphate metabolism was evaluated by multiple linear regressions. In women with osteoporosis, concentrations of BPA ranged from the lower limit of quantification (LLOQ) - 104 pg/ml and methyl paraben (MP) from LLOQ - 1120 pg/ml. The alternative bisphenols BPS, BPF and BPAF were all under the LLOQ. Except for MP, no further parabens were detected in the majority of samples. The multiple linear regression model found a positive association of BPA (beta=0.07, p<0.05) on calcium (Ca) concentrations. Furthermore, MP (beta=-0.232, p<0.05) was negatively associated with C-terminal telopeptide. These preliminary results suggest that these EDs may have effects on calcium-phosphate metabolism.

Department of Steroids and Proteofactors Institute of Endocrinology Prague Czech Republic

Osteocentrum Military University Hospital Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc19005360

003      

CZ-PrNML

005      

20210601145834.0

007      

ta

008      

190204s2018 xr f 000 0|eng||

009      

AR

024    7_

$a 10.33549/physiolres.934005 $2 doi

035    __

$a (PubMed)30484672

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Vítků, Jana $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic $7 xx0211876

245    10

$a Endocrine disruptors of the bisphenol and paraben families and bone metabolism / $c J. Vitku, L. Kolatorova, L. Franekova, J. Blahos, M. Simkova, M. Duskova, T. Skodova, L. Starka

520    9_

$a After menopause, when estrogen levels decrease, there is room for the activity of anthropogenic substances with estrogenic properties - endocrine disruptors (EDs) - that can interfere with bone remodeling and changes in calcium-phosphate metabolism. Selected unconjugated EDs of the bisphenol group - BPA, BPS, BPF, BPAF, and the paraben family - methyl-, ethyl-, propyl-, butyl-, and benzyl-parabens - were measured by high performance liquid chromatography-tandem mass spectrometry in the plasma of 24 postmenopausal women. Parameters of calcium-phosphate metabolism and bone mineral density were assessed. Osteoporosis was classified in 14 women, and 10 women were put into the control group. The impact of EDs on calcium-phosphate metabolism was evaluated by multiple linear regressions. In women with osteoporosis, concentrations of BPA ranged from the lower limit of quantification (LLOQ) - 104 pg/ml and methyl paraben (MP) from LLOQ - 1120 pg/ml. The alternative bisphenols BPS, BPF and BPAF were all under the LLOQ. Except for MP, no further parabens were detected in the majority of samples. The multiple linear regression model found a positive association of BPA (beta=0.07, p<0.05) on calcium (Ca) concentrations. Furthermore, MP (beta=-0.232, p<0.05) was negatively associated with C-terminal telopeptide. These preliminary results suggest that these EDs may have effects on calcium-phosphate metabolism.

650    _2

$a absorpční fotometrie $x metody $7 D015502

650    _2

$a senioři $7 D000368

650    _2

$a benzhydrylové sloučeniny $x škodlivé účinky $x krev $7 D001559

650    _2

$a kostní denzita $x účinky léků $x fyziologie $7 D015519

650    _2

$a remodelace kosti $x účinky léků $x fyziologie $7 D016723

650    _2

$a endokrinní disruptory $x škodlivé účinky $x krev $7 D052244

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a lidé středního věku $7 D008875

650    _2

$a postmenopauzální osteoporóza $x krev $x chemicky indukované $x diagnostické zobrazování $7 D015663

650    _2

$a parabeny $x škodlivé účinky $x metabolismus $7 D010226

650    _2

$a fenoly $x škodlivé účinky $x krev $7 D010636

655    _2

$a časopisecké články $7 D016428

700    1_

$a Kolátorová Sosvorová, Lucie $7 xx0140729 $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic

700    1_

$a Franeková, Lenka $7 xx0106766 $u Osteocentrum, Military University Hospital Prague, Czech Republic

700    1_

$a Blahoš, Jaroslav, $d 1930-2018 $7 jk01012224 $u Osteocentrum, Military University Hospital Prague, Czech Republic

700    1_

$a Simkova, M. $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic

700    1_

$a Dušková, Michaela $7 xx0080454 $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic

700    1_

$a Skodova, T. $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic

700    1_

$a Stárka, Luboslav, $7 jn19990209795 $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic $d 1930-

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 3 (2018), s. S455-S464

773    0_

$t Dr. Karel Šilink - The 110th anniversary of the birth $g (2018), s. S455-S464 $w MED00206981

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30484672 $y Pubmed

910    __

$a ABA008 $b A 4120 $c 266 $y 4 $z 0

990    __

$a 20190204 $b ABA008

991    __

$a 20210601145831 $b ABA008

999    __

$a ok $b bmc $g 1377933 $s 1043565

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2018 $b 67 $c Suppl. 3 $d S455-S464 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

BMC    __

$a 2018 $d S455-S464 $m Dr. Karel Šilink - The 110th anniversary of the birth $x MED00206981

LZP    __

$b NLK118 $a Pubmed-20190204